tm logo
FAVKEYZIN
REGISTERED

on 05 Feb 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME B.V.

Waarderweg 39NL-2031 BN Haarlem

NL

Serial Number

2189547 filed on 11th May 2022

Registration Number

TMA1220709 registered on 05th Feb 2024

Registration expiry Date

11th May 2032

Correspondent Address

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

FAVKEYZIN

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gast Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of neurological diseases and disorders, namely, schizophrenia pain, neuropathic pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2189547

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 07th Sep 2023
Agent Changed
Submitted for opposition 256
on 03rd Apr 2023
Notification of Possible Opposition Sent
Submitted for opposition 22
on 09th Mar 2023
Search Recorded
Submitted for opposition 20
on 09th Mar 2023
Examiner's First Report
Submitted for opposition 223
on 09th Mar 2023
Total Provisional Refusal
Submitted for opposition 257
on 02th Jun 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 01st Jun 2022
Created
Submitted for opposition 31
on 01st Jun 2022
Formalized
Submitted for opposition 228
on 11th May 2022
International Registration
Submitted for opposition 30
on 11th May 2022
Filed